肿瘤学临床试验与获益定义。
Clinical Trials in Oncology and Defining Benefit.
机构信息
Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
出版信息
Oncologist. 2018 Jan;23(1):135. doi: 10.1634/theoncologist.2017-0476. Epub 2017 Nov 13.
Abstract
In response to the recently published article by Goldberg et al., which discusses changing aspects of clinical trial design in oncology, this letter to the editor elaborates on the definitions of benefits, efficacy, and futility.
摘要
针对 Goldberg 等人最近发表的一篇讨论肿瘤学临床试验设计变化方面的文章，这封给编辑的信详细阐述了获益、疗效和无效的定义。
相似文献
1
Clinical Trials in Oncology and Defining Benefit.肿瘤学临床试验与获益定义。
Oncologist. 2018 Jan;23(1):135. doi: 10.1634/theoncologist.2017-0476. Epub 2017 Nov 13.
2
Biased by design? Clinical trials and patient benefit in oncology.设计存在偏差？肿瘤学中的临床试验与患者获益
Future Oncol. 2020 Jan;16(3):4419-4423. doi: 10.2217/fon-2019-0763. Epub 2019 Dec 11.
3
Effect of Crossover in Oncology Clinical Trials on Evidence Levels in Early Benefit Assessment in Germany.德国肿瘤学临床试验中交叉设计对早期获益评估中证据水平的影响。
Value Health. 2018 Jun;21(6):698-706. doi: 10.1016/j.jval.2017.09.010. Epub 2017 Nov 7.
4
CT2--the clinical trials control tower: overcoming barriers to opening oncology clinical trials.CT2——临床试验控制塔：克服肿瘤学临床试验启动的障碍
J Clin Oncol. 2007 Apr 1;25(10):1288; author reply 1288. doi: 10.1200/JCO.2006.10.3200.
5
Radiation Therapy Oncology Group. Research Plan 2002-2006. Surgical Oncology Committee.放射治疗肿瘤学组。2002 - 2006年研究计划。外科肿瘤学委员会。
Int J Radiat Oncol Biol Phys. 2001;51(3 Suppl 2):92-5.
6
Clarification regarding "phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties" and the accompanying commentary, "phase II cancer trials: out of control?".关于《2002年发表的II期试验：跨专业比较显示肿瘤学试验与其他医学专业之间存在显著设计差异》及随附评论《II期癌症试验：失控了吗？》的说明
Clin Cancer Res. 2007 Nov 1;13(21):6540. doi: 10.1158/1078-0432.CCR-07-1108.
7
Research plan for radiation oncology--1987: design and analysis of clinical trials.放射肿瘤学研究计划——1987：临床试验的设计与分析
Am J Clin Oncol. 1988 Jun;11(3):404-10.
8
Testing the wrong hypothesis in phase II oncology trials: there is a better alternative.在肿瘤学II期试验中检验错误的假设：存在更好的替代方案。
Clin Cancer Res. 2007 Feb 1;13(3):781-2. doi: 10.1158/1078-0432.CCR-06-2533.
9
Clinical trials in neuro-oncology.
Handb Clin Neurol. 2012;104:417-34. doi: 10.1016/B978-0-444-52138-5.00028-1.
10
Re: Quality of reporting of modern randomized controlled trials in medical oncology: a systematic review.
J Natl Cancer Inst. 2013 Feb 6;105(3):244-5. doi: 10.1093/jnci/djs510. Epub 2013 Jan 18.
本文引用的文献
1
The Evolution of Clinical Trials in Oncology: Defining Who Benefits from New Drugs Using Innovative Study Designs.肿瘤学临床试验的演进：使用创新研究设计定义谁能从新药中获益。
Oncologist. 2017 Sep;22(9):1015-1019. doi: 10.1634/theoncologist.2017-0153. Epub 2017 Jun 15.
Zotero 插件